INTI · Inhibitor Therapeutics, Inc. · Analyst Estimates
$0.11
At close · Oct 16
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events raise substantial doubt about the Company's ability to continue as a going concern. ... Because management's plans have not yet been fully executed and are not within the Company's control, the implementation of such plans cannot be considered probable. As a result, the Company has concluded that management's plans do not currently alleviate substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$19.12M
Shares
173.79M
Volume · Oct 16
3900
Avg daily vol (3M)
15.6K
Analyst Estimates
Compare analyst forecasts for Inhibitor Therapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Published by the company
No verified consensus is held yet; the last collection attempt failed and will be retried.
Consensus not yet available
No verified consensus is held yet; the last collection attempt failed and will be retried.